The deadly hantavirus has killed dozens of Native Americans, so when a reputable pharmaceutical company claims to have developed a vaccine against the deadly disease, it should be good news. But when ImmuVac asks Dr Isabel McLain to conduct a clinical trial of the vaccine on the Blackfeet reservation in Browning, Montana, the proposal gets a distinctly mixed response from both her and the suspicious Blackfeet. Is the new drug truly safe, or are the Blackfeet being used as human guinea pigs?
April Christofferson, an attorney with a background in biotechnology, lives in Seattle with her family. She holds an undergraduate degree in biology and did graduate work in veterinary medicine.